The rare inflammatory disorders treatment market sales was valued at US$12,664 million in 2021; analysts expect it will increase at a rate of 4.6% between 2022 and 2028 to reach US$17,335.8 million. The rare inflammatory disease treatment market has witnessed remarkable growth and innovation in recent years, owing to increasing awareness and advancements in medical …